Announcements
Sidley Represents Capricor Therapeutics in Common Stock Offering
October 24, 2024
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.
The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.
Contacts
Capabilities
Suggested News & Insights
The Wait is Over: SEC Proposes “Regulation Crypto Assets,” A Bespoke Offering Regime for Crypto Investment ContractsAugust 20, 2026Sidley Advises on EDL-Gen’s Debut International USD Bond Offering – the First by a Lao Corporate IssuerAugust 19, 2026Sidley Advises Goldman Sachs and BNP Paribas on India’s Largest-Ever Offer for Sale: Government of India’s US$3.3 Billion Stake Sale in LICAugust 17, 2026Sidley Advises on Janus Living’s US$533.6 Million Public OfferingAugust 14, 2026Sidley Advises Jefferies on the US$175 Million Upsized QIP of Belrise Industries LimitedAugust 12, 2026Sidley Represents MarineMax in Its US$1.5 Billion Sale to Blackstone Infrastructure Portfolio Company, Safe HarborAugust 10, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory